Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Screening for chlamydia and/or gonorrhea in primary health care: protocol for systematic review.

Pillay J, Moore A, Rahman P, Lewin G, Reynolds D, Riva J, Thériault G, Thombs B, Wilson B, Robinson J, Ramdyal A, Cadieux G, Featherstone R, Burchell AN, Dillon JA, Singh A, Wong T, Doull M, Traversy G, Courage S, MacGregor T, Johnson C, Vandermeer B, Hartling L.

Syst Rev. 2018 Dec 26;7(1):248. doi: 10.1186/s13643-018-0904-5.

2.

Parent experiences and information needs related to bronchiolitis: A mixed studies systematic review.

Gates M, Shulhan-Kilroy J, Featherstone R, MacGregor T, Scott SD, Hartling L.

Patient Educ Couns. 2019 May;102(5):864-878. doi: 10.1016/j.pec.2018.12.013. Epub 2018 Dec 13. Review.

PMID:
30573297
3.

Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update.

Pillay J, Boylan K, Newton A, Hartling L, Vandermeer B, Nuspl M, MacGregor T, Featherstone R, Carrey N.

Can J Psychiatry. 2018 Oct;63(10):661-678. doi: 10.1177/0706743718779950. Epub 2018 Jun 4.

4.

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.

MacGregor TP, Carter R, Gillies RS, Findlay JM, Kartsonaki C, Castro-Giner F, Sahgal N, Wang LM, Chetty R, Maynard ND, Cazier JB, Buffa F, McHugh PJ, Tomlinson I, Middleton MR, Sharma RA.

Sci Rep. 2018 May 8;8(1):7265. doi: 10.1038/s41598-018-24232-2.

5.

First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update [Internet].

Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M, MacGregor T, Jafri SHA, Featherstone R, Hartling L.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Mar.

6.

Bioequivalence and adhesion evaluation of transdermal clonidine following a change in excipient supplier.

Ehrlich J, Beck B, Thiedmann R, Marzin K, MacGregor T.

Int J Clin Pharmacol Ther. 2016 Oct;54(10):816-24. doi: 10.5414/CP202563.

PMID:
27390050
7.

Pediatric Neurosurgery Patients Need More than a Pediatric Neurosurgeon. Part II. A Clinical Report: In the USA Lack of Parent/Caregiver Compliance Interferes with the Patient Care Sequence.

MacGregor TL, James HE, Everett L, Childers DO Jr.

Pediatr Neurosurg. 2016;51(5):229-35. doi: 10.1159/000445897. Epub 2016 May 12.

PMID:
27165666
8.

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.

Findlay JM, Castro-Giner F, Makino S, Rayner E, Kartsonaki C, Cross W, Kovac M, Ulahannan D, Palles C, Gillies RS, MacGregor TP, Church D, Maynard ND, Buffa F, Cazier JB, Graham TA, Wang LM, Sharma RA, Middleton M, Tomlinson I.

Nat Commun. 2016 Apr 5;7:11111. doi: 10.1038/ncomms11111.

9.

Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered-Dose Inhaler.

MacGregor TR, ZuWallack R, Rubano V, Castles MA, Dewberry H, Ghafouri M, Wood CC.

Clin Transl Sci. 2016 Apr;9(2):105-13. doi: 10.1111/cts.12387. Epub 2016 Mar 6.

10.

Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.

Hill EJ, Roberts C, Franklin JM, Enescu M, West N, MacGregor TP, Chu KY, Boyle L, Blesing C, Wang LM, Mukherjee S, Anderson EM, Brown G, Dutton S, Love SB, Schnabel JA, Quirke P, Muschel R, McKenna WG, Partridge M, Sharma RA.

Clin Cancer Res. 2016 Apr 15;22(8):1922-31. doi: 10.1158/1078-0432.CCR-15-1489. Epub 2016 Feb 9.

11.

Baclofen pump catheter leakage after migration of the abdominal catheter in a pediatric patient with spasticity.

Dastgir A, Ranalli NJ, MacGregor TL, Aldana PR.

J Neurosurg Pediatr. 2015 Sep;16(3):335-9. doi: 10.3171/2015.2.PEDS14501. Epub 2015 Jun 5.

PMID:
26046690
12.

The value of head circumference measurements after 36 months of age: a clinical report and review of practice patterns.

James HE, Perszyk AA, MacGregor TL, Aldana PR.

J Neurosurg Pediatr. 2015 Aug;16(2):186-94. doi: 10.3171/2014.12.PEDS14251. Epub 2015 May 1. Review.

PMID:
25932781
13.

Evaluation of the first year of the Oxpal Medlink: A web-based partnership designed to address specific challenges facing medical education in the occupied Palestinian territories.

Penfold RS, Ali MA, Ali AM, Patel I, MacGregor T, Shankar S, Cahill TJ, Finlayson AE, Mahmud I.

JRSM Open. 2014 Feb 3;5(2):2042533313517692. doi: 10.1177/2042533313517692. eCollection 2014 Feb.

14.

Exposure-response modelling for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes.

Riggs MM, Seman LJ, Staab A, MacGregor TR, Gillespie W, Gastonguay MR, Woerle HJ, Macha S.

Br J Clin Pharmacol. 2014 Dec;78(6):1407-18. doi: 10.1111/bcp.12453.

15.

The Palestinian territories: barriers to healthcare and medical education and the strategic role of distance-learning partnerships in education systems strengthening.

Ali MA, Penfold RS, Patel I, MacGregor T, Cahill TJ, Alie AM, Shankar S, Nguyen M, Finlayson AE, Mahmud I.

Med Confl Surviv. 2014 Jan-Mar;30(1):11-8. No abstract available.

PMID:
24684019
16.

Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over study.

Giaquinto C, Anabwani G, Feiterna-Sperling C, Nuttall J, Mompati K, Königs C, Mensa FJ, Sabo JP, Yong CL, MacGregor TR, Nguyen T, Quinson AM.

Pediatr Infect Dis J. 2014 Jul;33(7):e173-9. doi: 10.1097/INF.0000000000000241.

PMID:
24378938
17.

Pediatric neurosurgery patients need more than a neurological surgeon: a clinical experience.

James HE, Macgregor TL, Childers DO Jr, La Corte E, Aldana PR.

Pediatr Neurosurg. 2013;49(2):63-8. doi: 10.1159/000356331. Epub 2013 Dec 5. Review.

PMID:
24335277
18.

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.

Hatch SB, Swift LP, Caporali S, Carter R, Hill EJ, MacGregor TP, D'Atri S, Middleton MR, McHugh PJ, Sharma RA.

Int J Cancer. 2014 Mar 15;134(6):1495-503. doi: 10.1002/ijc.28454. Epub 2013 Nov 14.

19.

Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes.

Riggs MM, Staab A, Seman L, MacGregor TR, Bergsma TT, Gastonguay MR, Macha S.

J Clin Pharmacol. 2013 Oct;53(10):1028-38. doi: 10.1002/jcph.147. Epub 2013 Aug 13.

PMID:
23940010
20.

Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.

MacGregor TP, Maughan TS, Sharma RA.

J Clin Pathol. 2012 Oct;65(10):867-71. Epub 2012 Jun 25. Review.

21.

Advanced registered nurse practitioners and physician assistants in the practice of pediatric neurosurgery: a clinical report.

James HE, MacGregor TL, Postlethwait RA, Hofrichter PB, Aldana PR.

Pediatr Neurosurg. 2011;47(5):359-63. doi: 10.1159/000337727. Epub 2012 May 9.

PMID:
22572571
22.

Creating a working group for prenatal diagnosis and management as a venue to facilitate neurosurgery health care delivery.

James HE, MacGregor TL, Aldana PR.

Pediatr Neurosurg. 2011;47(3):176-9. doi: 10.1159/000331567. Epub 2011 Oct 27.

PMID:
22041338
23.

Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine.

Lehr T, Yuan J, Hall D, Zimdahl-Gelling H, Schaefer HG, Staab A, MacGregor TR, Jayadev S.

Pharmacogenet Genomics. 2011 Nov;21(11):721-30. doi: 10.1097/FPC.0b013e32834a522e.

PMID:
21860339
24.

Is less clinical research being published by surgeons in the United Kingdom?

Phillips AW, Macgregor TP, Mihai R.

Surgeon. 2011 Oct;9(5):237-40. doi: 10.1016/j.surge.2010.10.002. Epub 2010 Nov 13.

PMID:
21843815
25.

Effect of tipranavir/ritonavir combination on the pharmacokinetics of tadalafil in healthy volunteers.

Garraffo R, Lavrut T, Ferrando S, Durant J, Rouyrre N, MacGregor TR, Sabo JP, Dellamonica P.

J Clin Pharmacol. 2011 Jul;51(7):1071-8. doi: 10.1177/0091270010379808. Epub 2011 Jan 5.

PMID:
21209236
26.

"Forgiving" a missed daily dose.

Macgregor TR.

AIDS Res Hum Retroviruses. 2011 Apr;27(4):345-6. doi: 10.1089/aid.2010.0273. Epub 2011 Feb 22. No abstract available.

27.

Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects.

Huang F, Allen L, Huang DB, Moy F, Vinisko R, Nguyen T, Rowland L, MacGregor TR, Castles MA, Robinson P.

J Clin Pharm Ther. 2012 Feb;37(1):81-8. doi: 10.1111/j.1365-2710.2010.01235.x. Epub 2010 Dec 5.

PMID:
21128991
28.

Titanium screws as fiducial markers for image-guided stereotactic proton irradiation in pediatric central nervous system tumors: a technical report.

Aldana PR, MacGregor TL, James HE, Marcus RB Jr, Indelicato DJ.

Pediatr Neurosurg. 2010;46(3):227-31. doi: 10.1159/000320147. Epub 2010 Nov 4.

PMID:
21051922
29.

Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study.

Huang F, Scholl P, Huang DB, MacGregor TR, Taub ME, Vinisko R, Castles MA, Robinson P.

Basic Clin Pharmacol Toxicol. 2011 Mar;108(3):163-70. doi: 10.1111/j.1742-7843.2010.00636.x. Epub 2010 Oct 27.

30.

Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers.

Sabo JP, Cong XJ, Kraft MF, Wallace L, Castles MA, Mauss S, MacGregor TR.

Eur J Clin Pharmacol. 2011 Mar;67(3):277-81. doi: 10.1007/s00228-010-0907-1. Epub 2010 Oct 12.

PMID:
20963404
31.

Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.

Huang F, Scholl P, Huang DB, MacGregor TR, Vinisko R, Castles MA, Berger F, Robinson P.

J Clin Pharmacol. 2011 Jul;51(7):1061-70. doi: 10.1177/0091270010376971. Epub 2010 Aug 12.

PMID:
20705951
32.

Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients.

Goebel FD, MacGregor TR, Sabo JP, Castles M, Johnson PA, Legg D, McCallister S.

HIV Clin Trials. 2010 Jan-Feb;11(1):28-38. doi: 10.1310/hct1101-28.

PMID:
20400409
33.

A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.

Dumond JB, Vourvahis M, Rezk NL, Patterson KB, Tien HC, White N, Jennings SH, Choi SO, Li J, Wagner MJ, La-Beck NM, Drulak M, Sabo JP, Castles MA, Macgregor TR, Kashuba AD.

Clin Pharmacol Ther. 2010 Jun;87(6):735-42. doi: 10.1038/clpt.2009.253. Epub 2010 Feb 10.

34.

In vitro-in vivo correlation for nevirapine extended release tablets.

Macha S, Yong CL, Darrington T, Davis MS, MacGregor TR, Castles M, Krill SL.

Biopharm Drug Dispos. 2009 Dec;30(9):542-50. doi: 10.1002/bdd.691.

PMID:
19876936
35.

Assessment of nevirapine bioavailability from targeted sites in the human gastrointestinal tract.

Macha S, Yong CL, MacGregor TR, Castles M, Quinson AM, Rouyrre N, Wilding I.

J Clin Pharmacol. 2009 Dec;49(12):1417-25. doi: 10.1177/0091270009344856. Epub 2009 Sep 30.

PMID:
19793911
36.

Leadership styles and outcome patterns for the nursing workforce and work environment: a systematic review.

Cummings GG, MacGregor T, Davey M, Lee H, Wong CA, Lo E, Muise M, Stafford E.

Int J Nurs Stud. 2010 Mar;47(3):363-85. doi: 10.1016/j.ijnurstu.2009.08.006. Epub 2009 Sep 24. Review.

PMID:
19781702
37.

Pharmacokinetic assessment of nevirapine and metabolites in human immunodeficiency virus type 1-infected patients with hepatic fibrosis.

Cammett AM, MacGregor TR, Wruck JM, Felizarta F, Miailhes P, Mallolas J, Piliero PJ.

Antimicrob Agents Chemother. 2009 Oct;53(10):4147-52. doi: 10.1128/AAC.00460-09. Epub 2009 Jul 20.

38.

Is there a role for cardiopulmonary exercise testing before major urological surgery.

MacGregor T, Patel N, Blick C, Arya M, Muneer A.

BJU Int. 2009 Sep;104(5):579-80. doi: 10.1111/j.1464-410X.2009.08517.x. Epub 2009 Apr 17. No abstract available.

39.

Pharmacokinetics of BILR 355 after multiple oral doses coadministered with a low dose of ritonavir.

Huang F, Drda K, MacGregor TR, Scherer J, Rowland L, Nguyen T, Ballow C, Castles M, Robinson P.

Antimicrob Agents Chemother. 2009 Jan;53(1):95-103. doi: 10.1128/AAC.00752-08. Epub 2008 Oct 27.

40.

Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.

Huang F, Koenen-Bergmann M, Macgregor TR, Ring A, Hattox S, Robinson P.

Antimicrob Agents Chemother. 2008 Dec;52(12):4300-7. doi: 10.1128/AAC.00363-08. Epub 2008 Sep 29.

41.

Factors contributing to nursing leadership: a systematic review.

Cummings G, Lee H, Macgregor T, Davey M, Wong C, Paul L, Stafford E.

J Health Serv Res Policy. 2008 Oct;13(4):240-8. doi: 10.1258/jhsrp.2008.007154. Review.

PMID:
18806183
42.

Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51).

Walmsley SL, Katlama C, Lazzarin A, Arestéh K, Pierone G, Blick G, Johnson M, Meier U, MacGregor TR, Leith JG.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):429-40. doi: 10.1097/QAI.0b013e318160a529.

PMID:
18176328
44.

Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry.

Rowland LS, MacGregor TR, Campbell SJ, Jenkins R, Pearsall AB, Morris JP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):252-60. Epub 2007 Jun 22.

PMID:
17618842
45.

Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir.

Chen L, Sabo JP, Philip E, Mao Y, Norris SH, MacGregor TR, Wruck JM, Garfinkel S, Castles M, Brinkman A, Valdez H.

Antimicrob Agents Chemother. 2007 Jul;51(7):2436-44. Epub 2007 May 7.

46.

Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.

Palmieri C, MacGregor T, Girgis S, Vigushin D.

J Clin Pathol. 2006 Dec;59(12):1334-6. Epub 2006 Oct 17.

47.

Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.

Kappelhoff BS, Huitema AD, van Leth F, Robinson PA, MacGregor TR, Lange JM, Beijnen JH; 2NN Study Group.

HIV Clin Trials. 2005 Sep-Oct;6(5):254-61.

PMID:
16306032
48.

Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers.

Mukwaya G, MacGregor T, Hoelscher D, Heming T, Legg D, Kavanaugh K, Johnson P, Sabo JP, McCallister S.

Antimicrob Agents Chemother. 2005 Dec;49(12):4903-10.

49.

Are adverse events of nevirapine and efavirenz related to plasma concentrations?

Kappelhoff BS, van Leth F, Robinson PA, MacGregor TR, Baraldi E, Montella F, Uip DE, Thompson MA, Russell DB, Lange JM, Beijnen JH, Huitema AD; 2NN Study Group.

Antivir Ther. 2005;10(4):489-98.

PMID:
16038474
50.

Dipyridamole bioavailability in subjects with reduced gastric acidity.

Derendorf H, VanderMaelen CP, Brickl RS, MacGregor TR, Eisert W.

J Clin Pharmacol. 2005 Jul;45(7):845-50.

PMID:
15951475

Supplemental Content

Loading ...
Support Center